BioReference Laboratories, Inc to Speak at the Jefferies Healthcare Conference

BioReference Laboratories, Inc (NASDAQ - “BRLI”) announced today that Marc D. Grodman M.D., President and Chief Executive Officer, is scheduled to speak at the Jefferies Conference on Tuesday, June 24, 2008, located in New York, NY. The BioReference Laboratories presentation is scheduled to begin at 8:00a.m., Eastern Time.

Those wishing to listen to the live audio Web cast may access it on the following site http://www.wsw.com/webcast/jeff26/brli and on the Company’s corporate Web site, www.bioreference.com. Please go to the site ten minutes before the presentation is ready to begin. The web cast can be found under the “Jefferies Healthcare Conference” link. You will need to register as well as download and install any necessary audio software. The Web cast will be archived for 30 days following the call.

About BioReference Laboratories, Inc.

BRLI is the third largest full service laboratory in the United States and the largest independent laboratory in the Northeastern market, primarily a clinical testing lab servicing physician offices with concentrations in the focused markets of esoteric testing, molecular diagnostic, anatomical pathology and correctional health care. GenPath is BRLI’s national oncology laboratory. Superior Science and superior technology have enabled GenPath to earn a reputation as one of the premier hematopathology laboratories in the country. GeneDx is the BRLI genetics laboratory and is typically recognized as the leading laboratory for testing of rare genetic diseases. GeneDx has now become a technology leader with GenomeDx, based on a CGH array platform and its upcoming nextgen sequence offerings that will be disease specific.